Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study

Patrocinadores de la web
Lilly
Angelini
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada